Metraipolis › archive › dc_261ff0fb3b72

Case Report: Furmonertinib dose escalation in heavily pretreated EGFR-mutant lung adenocarcinoma with diffuse brain metastases — Europe PMC PMID:41836239

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41836239
DOI
10.3389/fonc.2026.1782198
License (as archived)
solo-consultazione
Archived
2026-11-05T13:04:03.699Z
SHA-256 of the archived text
64b9ffb64278f405ef433444804dd82c81b31c96fc9e92fb95395e713dac7ce0
Stable URL of this page
https://metraipolis.com/documento/dc_261ff0fb3b72

How to cite

Case Report: Furmonertinib dose escalation in heavily pretreated EGFR-mutant lung adenocarcinoma with diffuse brain metastases — Europe PMC PMID:41836239 — Europe PMC (en), https://europepmc.org/article/MED/41836239 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_261ff0fb3b72 (Metraipolis archive dc_261ff0fb3b72, sha256 64b9ffb64278f405ef433444804dd82c81b31c96fc9e92fb95395e713dac7ce0)
BibTeX
@misc{dc261ff0fb3b72,
  title = {Case Report: Furmonertinib dose escalation in heavily pretreated EGFR-mutant lung adenocarcinoma with diffuse brain metastases — Europe PMC PMID:41836239},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41836239},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_261ff0fb3b72; sha256 64b9ffb64278f405ef433444804dd82c81b31c96fc9e92fb95395e713dac7ce0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41836239. Agents can read the archived copy with the MCP tool read_document.